Raymond James turned bullish on Advanced Micro Devices Inc (AMD), upgrading the stock to Strong Buy and assigning a $641 price target, representing potential upside of 33.77% from Tuesday's close.
Capricor Therapeutics Inc (CAPR) has won the favor of Oppenheimer's equity research team. The firm upgraded the shares from Perform to Outperform and moved its price target to $54, suggesting 551.39% additional upside for the stock.
Summit Therapeutics Inc (SMMT) received an upgrade from analysts at Bernstein, who also set their one-year price target on the stock to $12. They changed their rating on SMMT to Mkt Perform from Underperform in a recently issued research note.
Wells Fargo reduced its rating on Fidelity National Information Servcs Inc (FIS) stock to Equal Weight from Overweight and assigned the price target to $46.
National Bank Financial analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Nutrien Ltd (NTR) has been changed to Sector Perform from Outperform and the new price target is set at $77.
Analysts at Goldman downgraded Daqo New Energy Corp (DQ) stock to Sell from Neutral, and the new price target is set at $10.